Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Chmp    entities : Pfizer, inc.    save search

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union
Published: 2022-11-10 (Crawled : 15:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -3.15% H: 4.22% C: 4.22%
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: 1.72% H: 0.47% C: -0.31%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 3.05% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.59% H: 3.28% C: 3.06%

covid-19 chmp children vaccine positive
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union
Published: 2022-10-19 (Crawled : 16:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 0.36% C: -1.82%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.37% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.37% H: 0.37% C: -6.97%

comirnaty comirnaty® chmp children positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
Published: 2022-09-16 (Crawled : 12:20) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 0.91% C: -0.74%
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 1.15% C: -0.13%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.82% H: 3.27% C: 3.0%

comirnaty comirnaty® chmp authorization positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
Published: 2022-09-01 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -4.51% H: 1.07% C: 1.07%
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 3.35% C: 3.3%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -3.04% H: 0.45% C: 0.05%
BNTX | $86.82 0.75% 0.75% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.68% H: 1.61% C: 1.5%

covid-19 chmp vaccine positive
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Published: 2022-02-25 (Crawled : 13:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: -0.02% H: 0.0% C: 0.0%
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: -4.17% H: 0.0% C: 0.0%

treatment migraine positive chmp
Astellas Receives Positive CHMP Opinion for XTANDI™ (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer
Published: 2021-03-26 (Crawled : 13:15) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 1.71% C: 1.6%

prostate cancer positive cancer hormone chmp
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
Published: 2020-12-21 (Crawled : 15:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: -1.06% H: 0.32% C: 0.27%
BNTX | $86.82 0.75% 0.75% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 3.14% H: 0.43% C: -0.98%

covid vaccine positive chmp covid-19
BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Published: 2020-12-11 (Crawled : 15:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: 0.58% H: 0.24% C: -2.03%

positive treatment chmp urothelial carcinoma
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.